Acyclovir 1,000 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQV5W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,568
Award facts
- Contract value 100% obligated
- $10,567.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Acyclovir 1,000 mg/20 mL vials with a ceiling value of $10,567.63. This firm fixed-price delivery order, which must be completed by January 30, 2026, represents a single task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the subsidiary of parent company Cencora, Inc. and serves as a critical pharmaceutical distributor for federal medical procurement needs across military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen's comprehensive IDC with DLA valued at $999,999,999.00 through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies globally to support military healthcare programs. The Acyclovir supply fulfills part of the company's role as a Pharmaceutical Prime Vendor, providing essential antiviral medications to Defense Health Agency facilities and other federal healthcare systems. The award demonstrates AmerisourceBergen's continued capability to meet government pharmaceutical requirements across multiple therapeutic domains on an expedited basis.
Quick answers
Who was awarded contract SPE2DR26FQV5W?
SPE2DR26FQV5W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FQV5W worth?
The government has obligated $10,568 on SPE2DR26FQV5W.
Is contract SPE2DR26FQV5W an order under another contract?
Yes. SPE2DR26FQV5W is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV5W competed?
The extent of competition for SPE2DR26FQV5W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award